Search Reports

Showing search results for "All"

Below you can search for shortage and discontinuation reports that have been submitted for drug products by a company.

For more information on how to search reports, see “How to Search” section in the Website overview for public users, found in the About & Resources page.

The “Export results” button on the search reports page will create individual CSV files for shortage reports and discontinuation reports containing data from the search results. Please note that the two CSV files will be downloaded in a single .zip file. Users would then need to open the .zip file to access the CSV files.

To search by product, please refer to the Search Product page.

A public access API (application program interface) is also available to access shortage and discontinuation report data in an alternative format. Access the API here.

The export is also available for download through an extract zip file that is updated monthly. Access the Monthly Report extract here.

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

To
Select from the options in the checkboxes/dropdown menu below to filter your results by report type.
Filter by reports that have been designated Tier 3 by Health Canada. Learn more
Select from the options in the checkboxes/dropdown menu below to filter your results by status type

Status Brand name Company Name Strength(s) Date Updated View Report
Resolved SANDOZ IRBESARTAN HCT SANDOZ CANADA INCORPORATED 25MG 300MG 2024-01-09 200534
Resolved SANDOZ IRBESARTAN HCT SANDOZ CANADA INCORPORATED 25MG 300MG 2024-01-09 204738
Discontinued ALTACE HCT BAUSCH HEALTH, CANADA INC. 25MG 5MG 2024-01-09 214017
Discontinued ALTACE HCT BAUSCH HEALTH, CANADA INC. 12.5MG 10MG 2024-01-09 214024
Discontinued ALTACE HCT BAUSCH HEALTH, CANADA INC. 25MG 10MG 2024-01-09 214027
Discontinued ALTACE HCT BAUSCH HEALTH, CANADA INC. 12.5MG 2.5MG 2024-01-09 214011
Discontinued ALTACE HCT BAUSCH HEALTH, CANADA INC. 12.5MG 5MG 2024-01-09 214014
Resolved AURO-LEVETIRACETAM AURO PHARMA INC 500MG 2024-01-10 207402
Resolved AURO-CIPROFLOXACIN AURO PHARMA INC 250MG 2024-01-10 199590
Resolved SOLU-MEDROL PFIZER CANADA ULC 1G 2024-01-10 201990
Resolved RYBELSUS NOVO NORDISK CANADA INC 3MG 2024-01-10 214716
Resolved RYBELSUS NOVO NORDISK CANADA INC 14MG 2024-01-10 214721
Resolved CAMPRAL MYLAN PHARMACEUTICALS ULC 333MG 2024-01-10 213971
Resolved MYLAN-NAPROXEN/ESOMEPRAZOLE MR MYLAN PHARMACEUTICALS ULC 20MG 500MG 2024-01-10 205932
Avoided shortage PYRIDOXINE HYDROCHLORIDE INJECTION, USP MYLAN PHARMACEUTICALS ULC 100MG 2024-01-10 213767
Resolved PROPOFOL INJECTION BAXTER CORPORATION 10MG 2024-01-10 210583
Resolved COLESTID TABLETS PFIZER CANADA ULC 1G 2024-01-11 191596
Resolved SODIUM ACETATE INJECTION USP OMEGA LABORATORIES LIMITED 328MG 2024-01-11 213101
Resolved TEVA-CANDESARTAN TEVA CANADA LIMITED 8MG 2024-01-11 211985
Resolved ACT PRAMIPEXOLE TEVA CANADA LIMITED 1MG 2024-01-11 190722

Showing 20961 to 20980 of 27679